-
Acute experimental colitis in 5xFAD Alzheimer's disease mice leads to enhanced monocyte infiltration into the brain accompanied by reduced β-amyloid deposition Alzheimers Dement. (IF 13.0) Pub Date : 2025-06-02
Nanda K. Navalpur Shanmugam, Frank Zamudio, Deepak K. Vijaya Kumar, Kianna A. Barrett, Ryan VanDoren, Meng Chen, Olivia M. Barr, Sara Watson, Chih-Chung Jerry Lin, William A. Eimer, Mehdi Jorfi, Se Hoon Choi, Robert D. Moir, Rudolph E. TanziEmerging evidence has connected Alzheimer's disease (AD) to systemic inflammation, intestinal abnormalities, and altered gut microbiota, highlighting the significance of the gut–brain axis. Here, we investigated the impact of acute experimental colitis (acute colitis) on AD pathology.
-
Retinal optical coherence tomography angiography imaging in population studies for study of microvascular dysfunction in Alzheimer's disease and related dementias Alzheimers Dement. (IF 13.0) Pub Date : 2025-06-02
Amir H. Kashani, Tos T. J. M. Berendschot, Sophie Bonnin, Lucia Sobrin, Danilo Andrade De Jesus, Luisa Sanchez Brea, Ana Collazo Martinez, Rajiv Raman, Victor A. de Vries, Haifan Huang, , , , , , Tom MacGillivray, Wishal D. Ramdas, Frank C. T. van der HeideWidespread use of retinal optical coherence tomography angiography (OCT-A) imaging requires methodological and analytical consensus to ensure reproducible and accurate results in epidemiological studies on Alzheimer's disease and related dementias (ADRD).
-
Biofluid-based biomarker panels toward personalized medicine in dementia diagnostics Alzheimers Dement. (IF 13.0) Pub Date : 2025-06-04
Henrik ZetterbergAlzheimer's & Dementia publishes a set of papers exploring the diagnostic and prognostic capabilities of a novel cutting-edge multiplexed biomarker measurement technology across neurodegenerative dementias.
-
Common driving behaviors in older adults with dementia: Insights from a systematic literature review Alzheimers Dement. (IF 13.0) Pub Date : 2025-06-04
Ranuki Onara Hettiarachchige, Mark J. Rapoport, Gary Naglie, Evelyn Vingilis, Jane Seeley, Shahab Alizadeh, Sayeh BayatDementia impairs driving skills, but the specific driving behaviors affected are not fully understood. This project reviewed the literature on driving behaviors more common among people with dementia compared to age-matched healthy controls. A search of Scopus, Medline All, and Embase databases (1994 to September 2024) identified relevant studies. Articles were included if they addressed driving behaviors
-
Arteriolar degeneration and stiffness in cerebral amyloid angiopathy are linked to Aβ deposition and lysyl oxidase Alzheimers Dement. (IF 13.0) Pub Date : 2025-06-04
Lissa Ventura-Antunes, Alex Nackenoff, Wilber Romero-Fernandez, Yongchao Wang, Allison M. Bosworth, Alex Prusky, Emmeline Wang, Cristian Carvajal-Tapia, Alena Shostak, Hannah Harmsen, Bret Mobley, Jose Maldonado, Neely Womble, Elena Solopova, J. Caleb Snider, W. David Merryman, Ethan S. Lippmann, Matthew SchragThe morphological and molecular changes associated with the degeneration of arterioles in cerebral amyloid angiopathy (CAA) are incompletely understood.
-
A lifespan perspective on cognitive reserve and risk for dementia Alzheimers Dement. (IF 13.0) Pub Date : 2025-06-04
William S. Kremen, Malin Ericsson, Margaret Gatz, Ida K. Karlsson, Marianne Nygaard, Nancy L. Pedersen, Matthew S. PanizzonWe addressed whether higher education plays a causal role in reducing dementia risk by comparing two indices of cognitive reserve: education and young adult general cognitive ability (GCA).
-
Examining the association between synaptic density and neurofibrillary tau among cognitively impaired and unimpaired older adults with and without Alzheimer's disease pathology Alzheimers Dement. (IF 13.0) Pub Date : 2025-06-04
Alexandra H. DiFilippo, Erin M. Jonaitis, Gilda E. Ennis, Andrew K. McVea, Max McLachlan, Brecca Bettcher, Nicholas Schulz, Mary-Elizabeth Pasquesi, Nancy J. Davenport-Sis, Yer Thor, Ethan Grover, Nathaniel Chin, Todd E. Barnhart, Sanjay Asthana, Tobey J. Betthauser, Jonathan W. Engle, Sterling C. Johnson, Barbara B. Bendlin, Bradley T. ChristianSynapse loss is a key driver of cognitive decline in Alzheimer's disease (AD), yet its direct relationship with neurofibrillary tau tangle (NFT) burden remains unclear. This study leveraged positron emission tomography (PET) imaging to investigate the link between NFT accumulation and synaptic density in older adults with and without AD pathology.
-
Alzheimer's disease plasma biomarkers in the Midwestern Amish Alzheimers Dement. (IF 13.0) Pub Date : 2025-06-04
Ping Wang, Yeunjoo E. Song, Audrey Lynn, Kristy Miskimen, Alex Gulyayev, Michael B. Prough, Daniel A. Dorfsman, Renee A. Laux, Sarada L. Fuzzell, Sherri D. Hochstetler, Andrew F. Zaman, Larry D. Adams, Laura J. Caywood, Jason E. Clouse, Sharlene D. Herington, Patrice Whitehead, Yining Liu, Noel Moore, Paula Ogrocki, Alan J. Lerner, Anthony J. Griswold, Jeffery M. Vance, Michael L. Cuccaro, WilliamAlzheimer's disease (AD) plasma biomarkers are non-invasive measures of the key amyloid beta (Aβ) and tau pathologies. Validation and generalization studies are needed to fully understand their potential for AD prediction and diagnosis in the elderly population.
-
Cell-specific protein expression in Alzheimer's disease prefrontal cortex Alzheimers Dement. (IF 13.0) Pub Date : 2025-06-04
Maryam Gholampour, Malay K. Basu, Russell H. Swerdlow, Xinming Zhuo, Mohammad HaeriAnalyzing the proteomes of different brain cell types is fundamental for understanding the pathophysiology of Alzheimer's disease (AD). However, spatial analysis of these diverse and limited cell populations poses significant challenges.
-
Assessing the Global Impact of Brain Small Vessel Disease on Cognition: The Multi-Ethnic Study of Atherosclerosis Alzheimers Dement. (IF 13.0) Pub Date : 2025-06-04
Sokratis Charisis, Tanweer Rashid, Christina Dintica, Mitzi Gonzales, Hangfan Liu, Jeffrey B. Ware, Thomas R. Austin, Paul N. Jensen, Alison E. Fohner, Jordan E. Tanley, Jingzhong Ding, José A. Luchsinger, Bonnie Sachs, Ilya M. Nasrallah, R. Nick Bryan, Kathleen M. Hayden, David Wolk, Katya Rascovsky, Christos Davatzikos, William T. Longstreth, Kristine Yaffe, Sudha Seshadri, Susan R. Heckbert, TimothyWe aimed to examine the global impact of brain small vessel disease (SVD) on cognitive performance.
-
Lower prevalence of metabolic syndrome and its components in the prediagnostic phase of Parkinson’s disease npj Parkinsons Dis. (IF 6.7) Pub Date : 2025-06-04
Hila Avisar, Uri Greenbaum, Ruth Djaldetti, Boaz Lerner -
Effects of virtual reality on spatiotemporal gait parameters and freezing of gait in Parkinson’s disease npj Parkinsons Dis. (IF 6.7) Pub Date : 2025-06-04
Lei Ma, Bar Yosef, Ipek Talu, Daniel Batista, Emi Jenkens-Drake, Nanthia Suthana, Katy A Cross -
Proinflammatory and GABA eating bacteria in Parkinson's disease gut microbiome from a meta-analysis prospective npj Parkinsons Dis. (IF 6.7) Pub Date : 2025-06-03
Nour H. Marzouk, Hannah H. Rashwan, Mohamed El-Hadidi, Raghda Ramadan, Mohamed Mysara -
Resilience of striatal synaptic plasticity over early structural adaptations in premotor parkinsonism npj Parkinsons Dis. (IF 6.7) Pub Date : 2025-06-03
Leyre Merino-Galán, Marta Zamarbide, Arantzazu Belloso-Iguerategui, Marta C. Alonso-Moreno, Belén Gago, Alejandro Reinares-Sebastián, Javier Blesa, Dani Dumitriu, Ana Quiroga-Varela, María Cruz Rodríguez-Oroz -
Prediction of all-cause mortality in Parkinson’s disease with explainable artificial intelligence using administrative healthcare data npj Parkinsons Dis. (IF 6.7) Pub Date : 2025-06-02
You Hyun Park, Yong Wook Kim, Dae Ryong Kang, Sang Chul Lee, Seo Yeon Yoon -
Detection of emergency department patients at risk of dementia through artificial intelligence Alzheimers Dement. (IF 13.0) Pub Date : 2025-06-03
Inessa Cohen, Richard Andrew Taylor, Haipeng Xue, Isaac V. Faustino, Natalia Festa, Cynthia Brandt, Emily Gao, Ling Han, Siddarth Khasnavis, James M. Lai, Adam P. Mecca, Atharva Vinay Sapre, Juan Young, Michael Zanchelli, Ula HwangINTRODUCTIONThe study aimed to develop and validate the Emergency Department Dementia Algorithm (EDDA) to detect dementia among older adults (65+) and support clinical decision‐making in the emergency department (ED).METHODSIn a multisite retrospective study of 759,665 ED visits, electronic health record data from Yale New Haven Health (2014–2022) were used to train three supervised and semi‐unsupervised
-
Access to communication support for community-dwelling people with dementia: A mixed methods study exploring local perspectives within the United Kingdom context Age Ageing (IF 6.0) Pub Date : 2025-06-03
Anna Hockley, Deborah Moll, Jemima Littlejohns, Zoe Collett, Catherine HenshallIntroduction Communication difficulties occur in all dementia subtypes. This can affect individuals’ identity, relationships, and quality-of-life of people with dementia and their relatives. Professional guidelines recommend access to communication intervention, for example through speech and language therapy (SLT) services, but anecdotal evidence suggests that the type and availability of this provision
-
Glymphatic function associates with Alzheimer’s disease—signature region volumes, plasma biomarkers and white matter hyperintensity progression in cognitively unimpaired older adults Age Ageing (IF 6.0) Pub Date : 2025-06-03
Qian Chen, Danni Ge, Xinru Xu, Futao Chen, Shunshun Du, Yijun Bai, Dongming Liu, Yan Lei, Yajing Zhu, Cong Long, Jiaming Lu, Pin Lv, Xin Zhang, Bing ZhangBackground Brain glymphatic system is thought to play a critical role in the pathogenesis of Alzheimer’s disease (AD). Objective To investigate the relationships between glymphatic function and AD-signature region volumes, plasma biomarkers and disease progression in cognitively unimpaired older adults. Methods Two datasets comprising a total of 229 cognitively unimpaired older adults were enrolled
-
Frailty in older adults admitted to hospital: a six-year dual-centre retrospective study of over 53 000 clinical frailty scale assessments Age Ageing (IF 6.0) Pub Date : 2025-06-03
Emma Walker, Rebecca Winter, Luke Eliot HodgsonAim To examine frailty assessments in older patients admitted to hospital, and explore associations with sex, admission and discharge status. Methodology Worldwide, the prevalence of frailty is increasing. Stratifying frailty can be beneficial at a population level to improve public health and target local services. At an individual level, recognition of frailty can help inform prognosis and advanced
-
A new bleeding risk score specifically developed for direct oral anticoagulants in a geriatric population Age Ageing (IF 6.0) Pub Date : 2025-06-02
Matthieu Piccoli, George Pisica-Donose, Abdelhakim Hacil, Galdric Orvoën, Jean Philippe David, Judith Charbit, Rafaëlle Roth, Yara Antakly, Nicolas Boulloche, Ulric Vinsonneau, Stéphane Bouée, Pierre Krolak-Salmon, Laurent Fauchier, Pierre Jouanny, Guillaume Sacco, Fabienne Bellarbre, Joël Belmin, Puisieux François, Matthieu Lilamand, Elena Paillaud, Anne Sophie Boureau, Olivier Hanon, Jean-SébastienAlthough the use of direct oral anticoagulants increases in parallel with the increase in atrial fibrillation (AF) with age, none of the bleeding risk scores (HAS-BLED, HEMORR2HAGES, ATRIA nor RE-LY) have been developed in a geriatric population. Our study aimed to develop a bleeding risk score adapted to this specific population and this therapeutic class. Multicentre, longitudinal, prospective, observational
-
Central biogenic amine deficiency with concomitant exploratory behavioral deficits in Dnajc12 knock-out mice npj Parkinsons Dis. (IF 6.7) Pub Date : 2025-05-30
Isaac Bul Deng, Jordan Follett, Jesse D. Fox, Shannon Wall, Matthew J. Farrer -
Response to “Comment on ‘Independent associations of high‐density lipoprotein cholesterol and triglyceride levels with Alzheimer's disease and related dementias’ ” Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-31
Erin L. Ferguson, Thomas J. Hoffmann, Akinyemi Oni‐Orisan, Neil Risch, Ronald M. Krauss, Catherine A. Schaefer, Maria Glymour -
-
Heterogeneous treatment effects of GLP‐1RAs and SGLT2is on risk of Alzheimer's disease and related dementia in patients with type 2 diabetes: Insights from a real‐world target trial emulation Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-31
Huilin Tang, William T. Donahoo, Steven T. DeKosky, Yao An Lee, Pareeta Kotecha, Mikael Svensson, Jiang Bian, Jingchuan GuoINTRODUCTIONThis study assessed the heterogeneous treatment effects (HTEs) of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) on the risk of Alzheimer's disease and related dementias (ADRD).METHODSThis target trial emulation study included adults (≥ 50 years) with type 2 diabetes (T2D) and newly prescribed a GLP‐1RA, SGLT2i, or other second‐line
-
Caregiving at end‐of‐life: How do family structure and dementia status impact antidepressant and anxiolytic prescriptions among families? Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-31
Eli Iacob, Mike Hollingshaus, Rebecca L. Utz, Djin L. Tay, Katherine A. Ornstein, Rachael Alexander, Pamela Barrientos, Lee Ellington, Mike Newman, Tom Belnap, Amy M. Cizik, Ken R. Smith, Huong D. Meeks, Caroline E. StephensINTRODUCTIONEnd‐of‐life (EOL) caregiving is associated with stress and burden, especially for persons with dementia. Little is known, however, about how dementia diagnosis, family structure, and co‐residence influence the prevalence of antidepressants and anxiolytics (psychiatric prescriptions) among spouses and adult children during EOL caregiving.METHODSThis was a retrospective cohort study of spouses
-
Social determinants of health and their impact on depression in family caregivers of those with dementia: The importance of intermediary determinants Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-31
Hannah Cho, Yeji HwangINTRODUCTIONDementia family caregivers face a significant burden due to the progressive nature of the disease, which places them at high risk for depression. Because a lack of information is available on the social determinants of health that impact depression, this study investigated this relationship.METHODSThis study was a secondary data analysis using the 2017 National Health and Aging Trends Study
-
Impulsive-compulsive behaviours and striatal neuroactivity in mildly parkinsonian rats under D2/3 agonist and L-DOPA treatment npj Parkinsons Dis. (IF 6.7) Pub Date : 2025-05-29
Mirjam Wolfschlag, Elena Espa, Katrine Skovgård, Pär Halje, Maria Angela Cenci -
Dual defense: Opportunities and challenges of GLP‐1 receptor agonists in reducing dementia risk in type 2 diabetes! Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-30
Saman Adnan, Muniza Qureshi, Sania Arif, Kinza Fatima -
Feasibility of lifestyle interventions for cognition in adults with low education Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-30
Daniel O. Clark, Huiping Xu, Christy C. Tangney, Annie W. Lin, Shannon L. Risacher, Andrew J. Saykin, Robert V. Considine, Holly J. Garringer, Lyndsi Moser, Amy Carter, Catherine M. Miller, Briana Sprague, Christopher M. Callahan, Frederick W. UnverzagtINTRODUCTIONWe report the feasibility and cognitive outcomes of a stage 1b randomized trial testing 3 months of home‐delivered high polyphenol snacks (e.g., nuts, berries) and online speed of processing training among older adults with 12 or fewer years of education.METHODSOne hundred eighty participants were randomized to polyphenol‐rich snacks and online cognitive training, polyphenol snacks and
-
Repeated plasma p‐tau217 measurements to monitor clinical progression heterogeneity Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-30
Bjørn‐Eivind Kirsebom, Fernando Gonzalez‐Ortiz, Sinthujah Vigneswaran, Geir Bråthen, Ragnhild Eide Skogseth, Berglind Gísladóttir, Peter Harrison, Jonas Alexander Jarholm, Lene Pålhaugen, Arvid Rongve, Per Selnes, Betty Tjims, Michael Turton, Argonde C. Van Harten, Knut Waterloo, Henrik Zetterberg, Tormod Fladby, Kaj BlennowINTRODUCTIONHeterogeneity of clinical progression in Alzheimer's disease (AD) complicates the assessment of disease progression and treatment effects in trials. This study evaluates the potential of plasma phosphorylated tau‐217 (p‐tau217) to capture this heterogeneity.METHODSWe used k‐means clustering to analyze cognitive trajectories in amyloid beta –positive (Aβ+) cognitively normal (CN) and mild
-
Improving the safety and experience of transitions from hospital to home: a cluster randomised controlled trial of an intervention to involve older people in their care (Your Care Needs You) Age Ageing (IF 6.0) Pub Date : 2025-05-30
Jenni Murray, Kalpita Baird, Stephen Brealey, Laura Mandefield, Gerry Richardson, Jane O'Hara, Robbie Foy, Laura Sheard, Alison Cracknell, Alfredo Palacios, Simon Walker, Ed Breckin, Lubena Mirza, Ruth Baxter, Catherine Hewitt, Rebecca LawtonBackground Transitions from hospital to home are risky for older people. The role of patient involvement in supporting safe transitions is unclear. Objective To assess the clinical effectiveness of an intervention to improve the safety and experience of care transitions for older people. Trial design Cluster randomised controlled trial. Participants Eleven National Health Service acute hospital trusts
-
Acute NAD+ Supplementation via NMN Does Not Rescue Functional Impairment in a LPS-Induced Delirium Mouse Model J. Gerontol. A Biol. Sci. Med. Sci. (IF 4.3) Pub Date : 2025-05-30
M K Kirsten Chui, Prasanna Vadhana Ashok Kumaar, Birgit Schilling, Eric Verdin, John C NewmanDelirium is a serious neuropsychiatric condition that lacks an effective treatment intervention. A confusional state often brought on by acute illness, delirium is associated with acute inflammation and metabolic dysfunction. NAD+ is a metabolite involved in both cellular energy generation and immunomodulation, that has previously been found to promote metabolic function and reduce inflammation. Whether
-
Complement C4 exacerbates astrocyte-mediated neuroinflammation and promotes α-synuclein pathology in Parkinson’s disease npj Parkinsons Dis. (IF 6.7) Pub Date : 2025-05-28
Wenkai Zou, Liang Kou, Yiming Wang, Zongjie Jin, Nian Xiong, Tao Wang, Yun Xia -
Computer vision uncovers three fundamental dimensions of levodopa-responsive motor improvement in Parkinson’s disease npj Parkinsons Dis. (IF 6.7) Pub Date : 2025-05-28
Florian Lange, Diego L. Guarin, Esther Ademola, Dalia Mahdy, Gabriela Acevedo, Thorsten Odorfer, Joshua K. Wong, Jens Volkmann, Robert Peach, Martin Reich -
Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-29
Bess Frost, James B. Rowe, Rufus O. Akinyemi, Jose F. Abisambra, Nicholas J. Ashton, Matthias Brendel, Luc Buée, David Butler, Maria C. Carrillo, Peter Chung, Claire D. Clelland, Sarah L. DeVos, Kristophe Diaz, Rebecca M. Edelmayer, Fanny M. Elahi, Ratnavalli Ellajosyula, Colin Ewen, Igor Camargo Fontana, Marie‐Christine Galas, Oskar Hansson, Günter Höglinger, Kanta Horie, Agustín Ibanez, Linde JacobsRecent years have seen major advances in tau‐associated brain disorders through interdisciplinary research spanning molecular biology, neuroimaging, clinical trials, and therapeutic development. The Tau2024 Global Conference, hosted by the Alzheimer's Association, CurePSP, and Rainwater Charitable Foundation, showcased these efforts by bringing together researchers and experts worldwide to discuss
-
Correction to “Effects of a ketogenic and low‐fat diet on the human metabolome, microbiome, and foodome in adults at risk for Alzheimer's disease” Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-29
Dilmore AH, Martino C, Neth BJ, et al. Effects of a ketogenic and low-fat diet on the human metabolome, microbiome, and foodome in adults at risk for Alzheimer's disease. Alzheimer's Dement. 2023;4805-4816. https://doi.org/10.1002/alz.13007 The Conflict of Interest Statement is incomplete. The full Conflict of Interest Statement should be: Rima Kaddurah-Daouk is an inventor of key patents in the field
-
A tongue resistance training program improves strength, endurance, and swallowing in frail older adults with mild cognitive impairment: a double-blind randomized controlled trial. Geroscience (IF 5.3) Pub Date : 2025-05-29
Shu-Hua Kao,Ruey Chen,Pi-Yu Su,Kondwani Joseph Banda,Chien-Mei Sung,Chia-Hui Wang,Kai-Jo Chiang,Melati Fajarini,Kuei-Ru ChouBACKGROUND Age-associated decline in swallowing and tongue function is associated with mild cognitive impairment (MCI) and frailty. However, evidence regarding effectiveness of tongue resistance exercises in frail older adults with MCI is limited with methodological variations and lack of follow-up. OBJECTIVE To determine the effectiveness of a tongue resistance training program (TRTP) in improving
-
Mapping striatal functional gradients and associated gene expression in Parkinson’s disease with continuous cognitive impairment npj Parkinsons Dis. (IF 6.7) Pub Date : 2025-05-28
Xiaolu Li, Shuting Bu, Huize Pang, Hongmei Yu, Mengwan Zhao, Juzhou Wang, Yu Liu, Guoguang Fan -
Chronic stress induces depression-like behaviors and Parkinsonism via upregulating α-synuclein npj Parkinsons Dis. (IF 6.7) Pub Date : 2025-05-28
Danhao Xia, Min Xiong, Yingxu Yang, Xin Wang, Qiang Chen, Sheng Li, Lanxia Meng, Zhentao Zhang -
Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-28
Jie Wang, Qi Huang, Xing Chen, Zhiwen You, Kun He, Xiaoxie Mao, Yiyun Huang, Nicolai Franzmeier, Michael Schöll, Tengfei Guo, Jun Zhao, Yihui Guan, Ruiqing Ni, Binyin Li, Fang XieINTRODUCTIONWe investigated the associations of longitudinal synaptic loss and cognitive decline with tau burden and plasma biomarkers in Alzheimer's disease (AD).METHODSTwenty cognitively impaired (CI) individuals and 16 healthy controls (HC) underwent cognitive and plasma biomarker assessments, amyloid positron emission tomography (PET), tau PET, and synaptic density PET; after 1 year, tau and synaptic
-
Effects of reminiscence therapy for loneliness in older adults: a systematic review and meta-analysis Age Ageing (IF 6.0) Pub Date : 2025-05-28
Haiqi Yang, Qiqing Zhong, Bingyue Han, Yuhang Pu, Rendong He, Kexin Huang, Yongliang Jiao, Rui Han, Qinghuan Kong, Yong Jia, Li ChenBackground Loneliness has detrimental effects on the mental well-being of senior citizens. Reminiscence therapies have emerged as a potential intervention to alleviate loneliness. This study aimed to systematically review and quantitatively analyse the effects of reminiscence therapy on loneliness among older adults. Methods A comprehensive search was performed across 11 electronic databases, meta-analyses
-
Mobile phone use characteristics, genetic predisposition and the risk of Parkinson’s disease: a prospective cohort study Age Ageing (IF 6.0) Pub Date : 2025-05-28
Juanjuan Zhang, Junjie Zou, Yuerong He, Jiale Shen, Kunjuan Jing, Ruiqi An, Zhen Wang, Xiaoyan Yao, Chao Ren, Yang XiaWe investigated the association between mobile phone use characteristics and Parkinson’s disease (PD) risk and whether genetic predisposition modified these associations, utilising data from the UK Biobank. Participants using mobile phones for at least one hour weekly had a lower risk of PD compared to those using less than five minutes weekly (HR: 0.75, 95% CI: 0.65–0.87). Long-term users of mobile
-
Effects of electrical muscle stimulation on cognitive function and neuropathology in senescence-accelerated mouse (SAMP8) model of aging-associated cognitive decline. Geroscience (IF 5.3) Pub Date : 2025-05-28
Hanlin Jiang,Tingrui Zhao,Chunxiao He,Bin Liu,Wanlin Ai,Yuxin Chen,Hideki MoriyamaThe global increase in aging populations has heightened the urgency to develop effective interventions for age-related cognitive decline. Skeletal muscle has recently emerged as a potential modulator of brain health, particularly in the context of aging. This study investigates the effects of electrical muscle stimulation (EMS) on cognitive function and neuropathology in Senescence-Accelerated Mouse
-
Olfactory dysfunction increases progression to dementia in cognitively impaired older adults: a 12-year population-based study. Geroscience (IF 5.3) Pub Date : 2025-05-28
Javier Oltra,Ingrid Ekström,Maria Larsson,Jane Yan,Giulia Grande,Erika J LaukkaOlfactory deficits are hypothesized to precede cognitive decline and be independently associated with future dementia. Conversely, the concurrency of cognitive and olfactory impairments is expected to represent an advanced stage, associated with shorter time to diagnosis. Limited research has examined the association of isolated and concurrent cognitive and olfactory impairments with incident dementia
-
Baseline Plasma GDF15 and Recovery of Physical Function Following Total Knee Replacement in The Study of Physical Resilience and Aging J. Gerontol. A Biol. Sci. Med. Sci. (IF 4.3) Pub Date : 2025-05-28
William A Fountain, Nicholas Milcik, Nicholas Schmedding, Karen Bandeen-Roche, Mallak K Alzahrani, Brian Buta, Meredith Dobrosielski, Jackie Langdon, Frederick Sieber, Julius K Oni, Thomas Laskow, Qian-Li Xue, Ravi Varadhan, Jeremy WalstonGrowth-differentiation factor 15 (GDF15), a cytokine with the ability to regulate metabolic and inflammatory activity, is negatively associated with physical and cognitive function, and increases in circulation with age. Mechanistically, the expression of GDF15 is stimulated by mitochondrial stress across multiple tissues. We hypothesized elevations in basal circulating GDF15 were negatively associated
-
T cell responses towards PINK1 and α-synuclein are elevated in prodromal Parkinson’s disease npj Parkinsons Dis. (IF 6.7) Pub Date : 2025-05-26
Emil Johansson, Antoine Freuchet, Gregory P. Williams, Tanner Michealis, April Frazier, Irene Litvan, Jennifer G. Goldman, Roy N. Alcalay, David G. Standaert, Amy W. Amara, Natividad Stover, Edward A. Fon, Ronald B. Postuma, John Sidney, David Sulzer, Cecilia S. Lindestam Arlehamn, Alessandro Sette -
Sex differences in the confounders influencing the relationships linking socioeconomic factors and cognitive performance with family history of Alzheimer's disease and related dementias Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-27
Jun He, Brenda Cabrera‐Mendoza, Eleni Friligkou, Adam P. Mecca, Christopher H. van Dyck, Gita A. Pathak, Renato PolimantiINTRODUCTIONLimited information is available regarding sex differences in the relationship of socioeconomic status and cognitive performance with Alzheimer's disease and related dementias (ADRD) family history.METHODSLeveraging the UK Biobank (N = 448,100) and All of Us Research Program (N = 240,319), we conducted observational and genetically informed analyses to test the sex‐specific associations
-
Cognitive assessment tools for Arabic‐speaking older adults: A systematic review Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-27
Mayssan Kabalan, Ola Bazzi, Josleen Al‐Barathie, Ola El Zein, Lara Chehabeddine, Joanne Khabsa, Monique Chaaya, Carlos Mendes de Leon, Martine ElbejjaniThis systematic review aims to identify available cognitive assessments for Arabic‐speaking older adults and to assess their validity and performance. A comprehensive search was conducted using Medline, Embase, and APA PsycInfo up to November 2023, encompassing studies validating or using cognitive tools in Arabic for individuals aged ≥ 50. We identified 29 validation studies for 20 cognitive tools
-
Experimental modeling of Alzheimer's disease: Translational lessons from cross‐taxon analyses Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-27
Konstantin B. Yenkoyan, Maria M. Kotova, Kirill V. Apukhtin, David S. Galstyan, Tamara G. Amstislavskaya, Tatyana Strekalova, Murilo S. de Abreu, Vergine A. Chavushyan, Lee Wei Lim, Longen Yang, Denis D. Rosemberg, Allan V. KalueffAlzheimer's disease (AD) is a severely debilitating neurodegenerative disease with a rapidly increasing global prevalence, poorly understood causes, and no efficient treatments. Experimental models are valuable for studying AD pathogenesis, including amyloid beta and tau accumulation, synaptic dysfunction, and neuroinflammation. While no model fully reproduces the disease, we take an evolutionary biology
-
Predicting progression from MCI to dementia using cortical disarray measurement from diffusion MRI Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-27
Mario Torso, Pegah Khosropanah, Steven A. Chance, Gerard R. RidgwayBACKGROUNDThis study evaluates the capability of cortical microstructural measures from diffusion magnetic resonance imaging (MRI) to predict progression from mild cognitive impairment (MCI) to dementia, compared to commonly used macrostructural measures. Identification of high‐risk individuals can support both clinical practice and trials.METHODSStructural and diffusion MRI scans of 826 participants
-
Racial ethnic variations in the cardiometabolic determinants and blood pressure of white matter hyperintensities among females—The HABS‐HD Study Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-27
Cellas A. Hayes, Michelle C. Odden, Raul Vintimilla, Roland J. ThorpeINTRODUCTIONWhite matter hyperintensity volume (WMH), markers of cerebral small vessel disease, are disproportionately prevalent among Black/African American and Hispanic individuals. While cardiometabolic risk factors contribute to WMHs, their association across racial ethnic groups among females remains unclear. This study examines associations among cardiometabolic risk factors, blood pressure,
-
Study partner characteristics moderate the prediction of cognitive decline in aging Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-27
Olivia Horn, Reyna E. Hickey, Paul J. Nietert, Andreana Benitez, Stephanie AghamoosaINTRODUCTIONWe investigated whether study partner characteristics moderated the ability of informant measures to predict cognitive decline in a cognitively unimpaired sample.METHODSData were from 2164 cognitively unimpaired participants from the National Alzheimer's Coordinating Center and their study partners. Composite cognition scores were calculated at baseline and first follow‐up. Linear mixed
-
APOE4 carriers display loss of anticipatory cerebrovascular regulation across the Alzheimer's disease continuum Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-27
Jacqueline A. Palmer, Carolyn S. Kaufman, Alicen A. Whitaker‐Hilbig, Sandra A. BillingerBACKGROUNDMaintenance of cerebral blood flow during orthostasis is impaired with aging and associated with cognitive decline, but the effect of the apolipoprotein ɛ4 allele (APOE4) is unknown.METHODSOlder adults (n = 108) (APOE4 carriers, n = 47; non‐carriers, n = 61) diagnosed as having normal cognition (NC), mild cognitive impairment (MCI), or Alzheimer's disease (AD) underwent transcranial Doppler
-
Intergenerational upward educational mobility and cognitive performance: results from the Study of Latinos‐Investigation of Neurocognitive Aging (SOL‐INCA) Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-27
Erika Meza, Wassim Tarraf, Linda C. Gallo, Carmen R. Isasi, Krista M. Perreira, Melissa Lamar, Mayra L. Estrella, Martha Daviglus, Isabel E. Allen, Medellena Maria Glymour, Jacqueline M. Torres, Hector M. GonzálezINTRODUCTIONUpward educational attainment is associated with better cognitive function; differences by Hispanic/Latino heritage are unclear.METHODSWe analyzed data from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) and its ancillary study SOL‐Investigation of Neurocognitive Aging (SOL‐INCA; n = 3300) to compare cognitive function and 7‐year cognitive change between first‐generation
-
Enhancing participation of historically minoritized groups in Alzheimer disease and related dementias research: National Conference Report Alzheimers Dement. (IF 13.0) Pub Date : 2025-05-27
Jessica Mozersky, Araya Dimtsu Assfaw, Joyce E. Balls Berry, Krista L. Moulder, Andrea Denny, María Aranda, Sanjay Asthana, Ganesh Babulal, Beverly Berry, Amanda Boyd, Dedra Buchwald, Raina Croff, Jason Flatt, Mattew Gabel, Carey E. Gleason, Crystal M. Glover, Gina Green‐Harris, Darrell Hudson, Jonathan Jackson, David K. Johnson, Luis Medina, Scarlet Mendez, Sid O'Bryant, Van Ta Park, Monica W. ParkerThis paper reports on a Conference organized by the Washington University School of Medicine's (WUSM) Knight Alzheimer Disease Research Center (Knight ADRC), entitled “Enhancing Participation by Minoritized Groups in Alzheimer Disease and Related Dementia (ADRD) Research.” It builds on recommendations from a 2018 Workshop. Representatives from all 37 federally funded ADRCs described strategies to enhance
-
Association of body age and multiorgan ages with cognitive decline in older adults: a nationwide longitudinal study Age Ageing (IF 6.0) Pub Date : 2025-05-27
Maiwulamujiang Maimaitiyiming, Yun Yang, Xueyao Jia, Xinyu ZhangBackground It is unknown whether the relationship between ageing of different organs and cognitive decline varies in older adults. Objectives This study investigated the association of body ageing and organ-specific ageing with cognitive decline, and whether this relationship was strengthened by hearing loss. Methods The study included older adults free from cognitive impairment, drawn from the Chinese
-
Geroprotective applications of oleuropein and hydroxytyrosol through the hallmarks of ageing. Geroscience (IF 5.3) Pub Date : 2025-05-27
Anna Calabrò,Anna Aiello,Paula Silva,Calogero Caruso,Giuseppina Candore,Giulia AccardiGeroprotectors are compounds that target the underlying mechanisms of ageing to delay the onset of age-related diseases and extend both lifespan and health span. As ageing is driven by the accumulation of cellular damage, DNA instability, epigenetic changes, mitochondrial dysfunction, and chronic inflammation, the concept of geroprotection focuses on compounds that can mitigate these processes. Oleuropein
-
Tilorone attenuates high-fat diet-induced hepatic steatosis by enhancing BMP9-Smad1/5/8 signaling. Geroscience (IF 5.3) Pub Date : 2025-05-27
Barnabas Horvath,Judit Halasz,Norman Noel Tanner,Zoltan Marton Kohler,Gyorgy Trencsenyi,Laszlo Juhasz,Laszlo Rovo,Andras Kiss,Aniko Keller-PinterThe prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is rapidly increasing and is caused by excessive fat deposition in the liver due to non-alcoholic factors. Aging is a major risk factor for the development and progression of MASLD. In this study, we investigated the metabolic effects of tilorone, a synthetic small molecule, in a high-fat diet (HFD) mouse model, with
-
Cognitive and neuroimaging outcome of very prodromal dementia with Lewy bodies Geroscience (IF 5.3) Pub Date : 2025-05-25
Frédéric Blanc, Vincent Bouteloup, Claire Paquet, Marie Chupin, Florence Pasquier, Audrey Gabelle, Mathieu Ceccaldi, Paulo Loureiro de Sousa, Pierre Krolak-Salmon, Renaud David, Clara Fischer, Jean-François Dartigues, David Wallon, Olivier Moreaud, Mathilde Sauvée, Catherine Belin, Claire Roubaud, Anne Botzung, Alix Ravier, Catherine Demuynck, Izzie Namer, Marie-Odile Habert, Olivier Bousiges, BenoîtThe cognitive and neuroimaging evolution over the course of dementia with Lewy bodies (DLB) from prodromal stage — Pro-DLB (subjective (SCI) to mild cognitive impairment (MCI)) — is poorly understood. The aim of this study was to analyze from 5-year longitudinal data the trajectories of Pro-DLB patients. The “Lewy- MEMENTO” prospective clinical cohort recruited 773 patients for either SCI or MCI. The
-
Loss of microstructural integrity in left hemispheric white matter tracts is associated with poorer digits in noise understanding Geroscience (IF 5.3) Pub Date : 2025-05-26
Jordi H. C. Boons, Gertjan Dingemanse, Elisabeth J. Vinke, Bernd Kremer, Meike W. Vernooij, André GoedegebureAge-related hearing loss (ARHL) is a prevalent condition among older adults and is regarded as a potentially modifiable risk factor for dementia. Although multiple studies have investigated pure-tone thresholds as a measure for ARHL and its relationship to dementia, the potential role of the central auditory system has received little attention. To address this gap in the literature, this study investigates